| Focusing on the preventability of adverse drug reactions. GT Schumock, JP Thornton Hospital pharmacy 27 (6), 538-538, 1992 | 841 | 1992 |
| Pure red-cell aplasia and epoetin therapy CL Bennett, S Luminari, AR Nissenson, MS Tallman, SA Klinge, ... New England Journal of Medicine 351 (14), 1403-1408, 2004 | 563 | 2004 |
| Evidence of the economic benefit of clinical pharmacy services: 1996–2000 GT Schumock, MG Butler, PD Meek, LC Vermeulen, BV Arondekar, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (1 …, 2003 | 427 | 2003 |
| Economic considerations in Alzheimer's disease PD Meek, EK McKeithan, GT Schumock Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 18 (2P2 …, 1998 | 325 | 1998 |
| Economic evaluations of clinical pharmacy services—1988–1995 Publications Committee of the American College of Clinical Pharmacy, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 16 (6 …, 1996 | 300 | 1996 |
| The financial burden of cancer: estimates from a study of insured women with breast cancer. AM Arozullah, EA Calhoun, M Wolf, DK Finley, KA Fitzner, EA Heckinger, ... The journal of supportive oncology 2 (3), 271-278, 2004 | 259 | 2004 |
| The incident user design in comparative effectiveness research ES Johnson, BA Bartman, BA Briesacher, NS Fleming, T Gerhard, ... Pharmacoepidemiology and drug safety 22 (1), 1-6, 2013 | 249 | 2013 |
| Economic evaluations of clinical pharmacy services: 2001–2005 F Doloresco, J Hoffman, P Meek Pharmacotherapy 28 (11), 285e-323e, 2008 | 229 | 2008 |
| Factors that influence prescribing decisions GT Schumock, SM Walton, HY Park, EA Nutescu, JC Blackburn, JM Finley, ... Annals of Pharmacotherapy 38 (4), 557-562, 2004 | 183 | 2004 |
| Exploring the use of social network methods in designing healthcare quality improvement teams D Meltzer, J Chung, P Khalili, E Marlow, V Arora, G Schumock, R Burt Social science & medicine 71 (6), 1119-1130, 2010 | 178 | 2010 |
| The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations BD Stein, A Bautista, GT Schumock, TA Lee, JT Charbeneau, ... Chest 141 (1), 87-93, 2012 | 170 | 2012 |
| The research on adverse drug events and reports (RADAR) project CL Bennett, JR Nebeker, EA Lyons, MH Samore, MD Feldman, JM McKoy, ... Jama 293 (17), 2131-2140, 2005 | 169 | 2005 |
| National trends in prescription drug expenditures and projections for 2016 GT Schumock, EC Li, KJ Suda, MD Wiest, JA Stubbings, LM Matusiak, ... American Journal of Health-System Pharmacy 73 (14), 1058-1075, 2016 | 154 | 2016 |
| Prioritizing future research on off‐label prescribing: results of a quantitative evaluation SM Walton, GT Schumock, KV Lee, GC Alexander, D Meltzer, RS Stafford Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (12 …, 2008 | 130 | 2008 |
| Antibiotic expenditures by medication, class, and healthcare setting in the United States, 2010–2015 KJ Suda, LA Hicks, RM Roberts, RJ Hunkler, LM Matusiak, GT Schumock Clinical Infectious Diseases 66 (2), 185-190, 2018 | 127 | 2018 |
| Clopidogrel‐associated bleeding and related complications in patients undergoing coronary artery bypass grafting AS Pickard, RC Becker, GT Schumock, CB Frye Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (3 …, 2008 | 105 | 2008 |
| Impact of Parkinson’s disease and its pharmacologic treatment on quality of life and economic outcomes RT Scheife, GT Schumock, A Burstein, MD Gottwald, MS Luer American Journal of Health-System Pharmacy 57 (10), 953-962, 2000 | 105 | 2000 |
| Guidelines for acute decompensated heart failure treatment RJ DiDomenico, HY Park, MR Southworth, HM Eyrich, RK Lewis, ... Annals of Pharmacotherapy 38 (4), 649-660, 2004 | 98 | 2004 |
| Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients JD Seeger, SX Kong, GT Schumock Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 18 (6 …, 1998 | 92 | 1998 |
| Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports … LA Ladewski, SM Belknap, JR Nebeker, O Sartor, EA Lyons, TC Kuzel, ... Journal of clinical oncology 21 (20), 3859-3866, 2003 | 90 | 2003 |